Search results for "Metabolic disease"

showing 10 items of 778 documents

Differences in ano-neorectal physiology of ileoanal and coloanal reconstructions for restorative proctectomy

2010

Objective  Restorative proctectomy with straight coloanal anastomosis (CAA) and restorative proctocolectomy with ilealpouch-anal anastomosis (IPAA) are options for maintaining bowel integrity after rectal resection. The aim of this study was to compare clinical function and anorectal physiology in patients treated with CAA and IPAA. Method  Three-dimensional vector-manometry and neorectal volumetry were performed in straight CAA [53 patients (34 male)] and IPAA [61 patients (39 male)] for ulcerative colitis. Function was assessed using a 14 day incontinence diary. Results  Function was similar in both groups, but neorectal compliance and threshold volumes for sensation, urge and maximum tol…

Malemedicine.medical_specialtyManometrymedicine.medical_treatmentAnal CanalAnastomosismental disordersHumansMedicineIn patientDefecationColoanal anastomosisAgedAged 80 and overbusiness.industryProctocolectomyProctocolectomy RestorativeRectumGastroenterologynutritional and metabolic diseasesRecovery of FunctionMiddle Agedmedicine.diseaseUlcerative colitisSurgerymedicine.anatomical_structureSphincterDefecationColitis UlcerativePouchbusinessFecal IncontinenceFollow-Up StudiesColorectal Disease
researchProduct

Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity.

1992

The present study was carried out to evaluate systolic and diastolic parameters in overweight and moderately obese, but otherwise healthy subjects, and in a lean control group, to determine whether degree and duration of obesity can influence left ventricular function. A total of 27 subjects, 17 overweight or with moderate obesity and 10 lean, healthy subjects were included. Patients were divided into three groups according to their body mass index (BMI) and to Garrow's criteria as follows: lean control group (BMI less than 25 kg.m-2); overweight subjects (BMI from 25 to 30 kg.m-2); moderately obese subjects (BMI greater than 30 less than 40 kg.m-2). Systolic and diastolic parameters were m…

Malemedicine.medical_specialtyMean arterial pressureSettore MED/09 - Medicina InternaTime FactorsSystoleDiastoleBlood PressureOverweightVentricular Function LeftRadionuclide angiographyDiastoleInternal medicinemedicineHumansObesitySystoleEjection fractionmedicine.diagnostic_testbusiness.industryBody WeightInfant Newbornnutritional and metabolic diseasesStroke VolumeStroke volumeMiddle AgedSettore MED/11 - Malattie Dell'Apparato CardiovascolareEndocrinologyLeft ventricular function Systolic function diastolic function peak filling rate obesity radionuclide angiography.CardiologyRegression AnalysisFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBody mass indexEuropean heart journal
researchProduct

Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease

1997

Abstract BACKGROUND & AIMS: Clinical significance and duration of insufficient release of pancreatic enzymes in childhood celiac disease have not been clarified. The aim of this study was to evaluate the role that pancreatic impairment plays in growth recovery and the duration of this impairment. METHODS: Forty-six patients with celiac disease who had a median age of 2.5 years were enrolled. Fecal chymotrypsin level was determined at diagnosis and then every 15 days after the beginning of a gluten-free diet in all patients. RESULTS: At diagnosis, 17 of 46 patients with celiac disease had subnormal fecal chymotrypsin values. During the gluten-free diet, a progressive reduction in the percent…

Malemedicine.medical_specialtyPancreatic diseaseGlutensGastroenterologyCoeliac diseaseImmunopathologyInternal medicineChymotrypsinHumansMedicineClinical significanceChildPancreaschemistry.chemical_classificationChymotrypsinHepatologybiologybusiness.industryBody WeightGastroenterologyInfantnutritional and metabolic diseasesmedicine.diseaseGlutenDietCeliac DiseaseEl NiñochemistryChild Preschoolbiology.proteinFemaleGluten freebusinessGastroenterology
researchProduct

Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pres…

2019

OBJECTIVE: Hyperuricemia has been associated with high blood pressure (BP) values, diabetes mellitus, metabolic syndrome and chronic kidney disease (CKD). In the present study, we assessed the gender-related relationships between serum uric acid (SUA) and cardionephrometabolic variables in central and east European hypertensive patients. METHODS: A total of 3206 treated hypertensive patients with available SUA levels from the BP-CARE study was analyzed. Correlations among SUA, BP values, BP control, diabetes mellitus, metabolic syndrome and CKD were performed according to gender. RESULTS: Twenty-five percent of the whole population showed hyperuricemia (28% in women and 23% in men). These p…

Malemedicine.medical_specialtyPhysiologyCross-sectional studyBlood PressureComorbidityHyperuricemia030204 cardiovascular system & hematologyurologic and male genital diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineSex FactorsRisk FactorsDiabetes mellitusInternal medicineInternal MedicinemedicineDiabetes MellitusPrevalenceHumans030212 general & internal medicineHyperuricemiaEurope EasternRenal Insufficiency ChronicAgedMetabolic Syndromebusiness.industrynutritional and metabolic diseasesMiddle AgedCardiovascular riskKidney damagemedicine.diseaseComorbidityUric AcidBlood pressureCross-Sectional StudieschemistryHypertensionUric acidFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessKidney diseaseJournal of hypertension
researchProduct

Efficacy and safety of ezetimibe added to atorvastatin versus atorvastatin uptitration or switching to rosuvastatin in patients with primary hypercho…

2013

Hypercholesterolemic patients (n = 1,547) at high atherosclerotic cardiovascular disease risk with low-density lipoprotein cholesterol (LDL-C) levels ≥100 and ≤160 mg/dl while treated with atorvastatin 10 mg/day entered a multicenter, randomized, double-blind, active-controlled, clinical trial using two 6-week study periods. Period I compared the efficacy/safety of (1) adding ezetimibe 10 mg (ezetimibe) to stable atorvastatin 10 mg, (2) doubling atorvastatin to 20 mg, or (3) switching to rosuvastatin 10 mg. Subjects in the latter 2 groups who persisted with elevated LDL-C levels (≥100 and ≤160 mg/dl) after period I, entered period II; subjects on atorvastatin 20 mg had ezetimibe added to th…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaAtorvastatinHypercholesterolemiaUrologylaw.inventionchemistry.chemical_compoundEzetimibeRandomized controlled trialDouble-Blind Methodlawhealth services administrationInternal medicineprimary hypercholesterolemiaatorvastatin; ezetimibe; rosuvastatin; primary hypercholesterolemiamedicineAtorvastatinHumansRosuvastatinIn patientPyrrolescardiovascular diseasesRosuvastatin CalciumAgedSulfonamidesCholesterolbusiness.industryAnticholesteremic Agentsnutritional and metabolic diseasesCholesterol LDLMiddle AgedEzetimibeClinical trialFluorobenzenesRosuvastatin CalciumLogistic ModelsPyrimidineschemistryHeptanoic AcidsCardiologyAzetidineslipids (amino acids peptides and proteins)Drug Therapy CombinationFemaleCardiology and Cardiovascular Medicinebusinessrosuvastatinmedicine.drugThe American journal of cardiology
researchProduct

Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy

2014

This study was designed to evaluate the prevalence of cardiometabolic comorbidities and the changes in left ventricular geometry and function in 135 subjects subgrouped according to low or normal total adiponectin plasma (ADPN) levels. Left ventricular (LV) internal diameter/height, total LV mass (LVM) and LVM index (LVMI), relative wall thickness (RWT), LV ejection fraction by echocardiography and diastolic parameters by pulsed-wave Doppler were calculated. Body mass index (BMI) (p < 0.0001), waist-to-hip ratio (p < 0.03), triglycerides (p < 0,001), prevalence of obesity (p < 0.005), visceral obesity (p < 0.003), left ventricular hypertrophy (LVH) (p < 0.001), metabolic syndrome (p < 0.000…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaDiastoleBlood PressureComorbidityLeft ventricular hypertrophyBody Mass IndexCoronary artery diseaseMetabolic DiseasesInternal medicineInternal MedicinemedicineHumansObesityAgedAged 80 and overEjection fractionAdiponectinbusiness.industrymedicine.diseaseAdiponectin Cardiometabolic comorbidities Left ventricular hypertrophyBlood pressureCardiovascular DiseasesEmergency MedicineCardiologyFemaleHypertrophy Left VentricularAdiponectinMetabolic syndromebusinessBody mass indexMetabolism Inborn Errors
researchProduct

The relationships between lipid ratios and arterial stiffness

2017

Although dyslipidemia is associated with cardiovascular disease, there are conflicting data about the role of serum lipids and their ratios in promoting arterial stiffness. The authors aimed to compare serum lipid profiles to predict arterial stiffness, which was assessed by brachial‐ankle pulse wave velocity in young Chinese men. A total of 1015 participants aged 18 to 44 years without serious comorbidities were recruited for conventional detection. Anthropometrics, brachial‐ankle pulse wave velocity, serum lipids, and other laboratory data were measured. Univariate analysis and multivariate logistic regression were performed to examine the relationship between serum lipid profiles and bra…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaLipoproteinsEndocrinology Diabetes and Metabolism030204 cardiovascular system & hematology03 medical and health sciencesVascular Stiffness0302 clinical medicineInternal medicineInternal MedicineHumansMedicine030212 general & internal medicineARTERIOSCLEROSIS - ARTERIAL STIFFNESS - LIPIDS - HYPERTENSIONSettore MED/14 - Nefrologiabusiness.industrynutritional and metabolic diseasesmedicine.diseaseLipidsSettore MED/11 - Malattie Dell'Apparato CardiovascolareSurgeryHypertensionArterial stiffnessCardiologyArterial Stiffnesslipids (amino acids peptides and proteins)Cardiology and Cardiovascular Medicinebusiness
researchProduct

Decreased plasma soluble RAGE in patients with hypercholesterolemia: Effects of statins

2007

The receptor for advanced glycation endproducts (RAGE) is overexpressed at sites of vascular pathology. A soluble RAGE isoform (sRAGE) neutralizes the ligand-mediated damage by acting as a decoy. We hypothesized that in hypercholesterolemia up-regulation of the ligand-RAGE axis may bridge impairment of nitric oxide biosynthesis with oxidative stress. We measured in 60 hypercholesterolemic patients and 20 controls plasma total sRAGE levels, urinary 8-iso-prostaglandin (PG) F(2alpha) excretion, and plasma levels of asymmetric dimethylarginine (ADMA). The effects of two structurally different statins (pravastatin and atorvastatin) on these parameters were analyzed in 20 hypercholesterolemic su…

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaStatinmedicine.drug_classAtorvastatinHypercholesterolemiaReceptor for Advanced Glycation End ProductsFree radicalsArginineDinoprostNitric Oxidemedicine.disease_causeBiochemistrychemistry.chemical_compoundDouble-Blind MethodPhysiology (medical)Internal medicineHyperlipidemiaAtorvastatinmedicineHumansPyrrolesReceptors ImmunologicEndothelial dysfunctionPravastatinChemistryVascular diseaseAnticholesteremic AgentsStatinnutritional and metabolic diseasesMiddle AgedAtherosclerosismedicine.diseaseADMACross-Sectional StudiesHyperlipidemiaEndocrinologyHeptanoic AcidsOxidative streFemalelipids (amino acids peptides and proteins)Hydroxymethylglutaryl-CoA Reductase InhibitorsNitric Oxide SynthaseAsymmetric dimethylarginineOxidative stressPravastatinsRAGEmedicine.drugFree Radical Biology and Medicine
researchProduct

Effects of fluvastatin slow-release (XL 80 mg) versus simvastatin (20 mg) on the lipid triad in patients with type 2 diabetes.

2005

The lipid triad is the association of small, dense (sd) low-density lipoprotein (LDL), low high-density lipoprotein (HDL), and hypertriglyceridemia, all of which play a role in coronary artery disease in patients with type 2 diabetes. Although statins have demonstrated clear positive effects on cardiovascular morbidity/mortality in patients with diabetes and on single components of the lipid triad, it remains controversial whether they affect all components of the triad in these patients. Therefore, we performed a single-center, parallel-group, prospective, randomized, open-label, blinded-endpoint (PROBE)-type comparison of fluvastatin extended-release (XL) 80 mg (n=48) and simvastatin 20 m…

Malemedicine.medical_specialtySimvastatinIndolesHDLApolipoprotein BSmall dense LDLType 2 diabetesTriglycerideLDLFatty Acids MonounsaturatedFluvastatin XLInternal medicineDiabetes mellitusType 2 diabetes mellitusmedicineHumansPharmacology (medical)Prospective StudiesFluvastatinAgedHypertriglyceridemiabiologybusiness.industryAnticholesteremic AgentsApoA-IHypertriglyceridemianutritional and metabolic diseasesType 2 Diabetes MellitusGeneral MedicineMiddle Agedmedicine.diseaseLipoproteins LDLEndocrinologyDiabetes Mellitus Type 2SimvastatinDelayed-Action Preparationsbiology.proteinlipids (amino acids peptides and proteins)FemaleApoBbusinessLipoproteins HDLFluvastatinmedicine.drugLipoproteinAdvances in therapy
researchProduct

Skin Sodium Accumulates in Psoriasis and Reflects Disease Severity

2020

Sodium can accumulate in the skin at concentrations exceeding serum levels. A high sodium environment can lead to pathogenic T helper 17 cell expansion. Psoriasis is a chronic inflammatory skin disease in which IL-17. producing T helper 17 cells play a crucial role. In an observational study, we measured skin sodium content in patients with psoriasis and in age-matched healthy controls by Sodium-23 magnetic resonance imaging. Patients with PASI > 5 showed significantly higher sodium and water content in the skin but not in other tissues than those with lower PASI or healthy controls. Skin sodium concentrations measured by Sodium-23 spectroscopy or by atomic absorption spectrometry in ashed-…

Malemedicine.medical_specialtySodiumchemistry.chemical_elementInflammationImiquimodDermatologySodium ChlorideLymphocyte ActivationSeverity of Illness IndexBiochemistryArticleMiceInternal medicinePsoriasismedicineExtracellularAnimalsHumansPsoriasisT helper 17 cellMolecular BiologyCells CulturedSkinintegumentary systembusiness.industrySpectrophotometry AtomicSpectrum AnalysisInterleukin-17SodiumCell DifferentiationCell Biologymedicine.diseasePathophysiologyMice Inbred C57BLEndocrinologychemistryCardiovascular and Metabolic DiseasesTh17 Cellsmedicine.symptombusinessIntracellularmedicine.drugJournal of Investigative Dermatology
researchProduct